BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoo EJ, Park JC, Kim EH, Park CH, Shim CN, Lee HJ, Chung HS, Lee H, Shin SK, Lee SK, Lee CG, Lee YC. Prognostic value of neutrophil-to-lymphocyte ratio in patients treated with concurrent chemoradiotherapy for locally advanced oesophageal cancer. Digestive and Liver Disease 2014;46:846-53. [DOI: 10.1016/j.dld.2014.05.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Yodying H, Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Yamada M, Uchida E. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis. Ann Surg Oncol 2016;23:646-54. [DOI: 10.1245/s10434-015-4869-5] [Cited by in Crossref: 164] [Cited by in F6Publishing: 176] [Article Influence: 23.4] [Reference Citation Analysis]
2 Salim DK, Mutlu H, Eryilmaz MK, Salim O, Musri FY, Tural D, Gündüz Ş, Coşkun HŞ. Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer. Mol Clin Oncol 2015;3:839-42. [PMID: 26171192 DOI: 10.3892/mco.2015.557] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
3 Deng M, Ma X, Liang X, Zhu C, Wang M. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Oncotarget 2017;8:37200-7. [PMID: 28380461 DOI: 10.18632/oncotarget.16553] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
4 Abbate V, Dell'Aversana Orabona G, Salzano G, Bonavolontà P, Maglitto F, Romano A, Tarabbia F, Turri-Zanoni M, Attanasi F, Di Lauro AE, Iaconetta G, Califano L. Pre-treatment Neutrophil-to-Lymphocyte Ratio as a predictor for occult cervical metastasis in early stage (T1-T2 cN0) squamous cell carcinoma of the oral tongue. Surg Oncol 2018;27:503-7. [PMID: 30217309 DOI: 10.1016/j.suronc.2018.06.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
5 Li C, Lin JW, Yeh HL, Chuang CY, Chen CC. Good prediction of treatment responses to neoadjuvant chemoradiotherapy for esophageal cancer based on preoperative inflammatory status and tumor glucose metabolism. Sci Rep 2021;11:11626. [PMID: 34078965 DOI: 10.1038/s41598-021-90753-y] [Reference Citation Analysis]
6 Fang P, Shiraishi Y, Verma V, Jiang W, Song J, Hobbs BP, Lin SH. Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation. Int J Part Ther 2018;4:23-32. [PMID: 30079369 DOI: 10.14338/IJPT-17-00033.1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 7.2] [Reference Citation Analysis]
7 Bowen RC, Little NAB, Harmer JR, Ma J, Mirabelli LG, Roller KD, Breivik AM, Signor E, Miller AB, Khong HT. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis. Oncotarget 2017;8:32171-89. [PMID: 28418870 DOI: 10.18632/oncotarget.16291] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 9.3] [Reference Citation Analysis]
8 Cox S, Hurt C, Grenader T, Mukherjee S, Bridgewater J, Crosby T. The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol 2017;125:154-9. [PMID: 28893415 DOI: 10.1016/j.radonc.2017.08.023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
9 Davuluri R, Jiang W, Fang P, Xu C, Komaki R, Gomez DR, Welsh J, Cox JD, Crane CH, Hsu CC, Lin SH. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy. Int J Radiat Oncol Biol Phys 2017;99:128-35. [PMID: 28816138 DOI: 10.1016/j.ijrobp.2017.05.037] [Cited by in Crossref: 91] [Cited by in F6Publishing: 95] [Article Influence: 18.2] [Reference Citation Analysis]
10 Jagadesham VP, Lagarde SM, Immanuel A, Griffin SM. Systemic inflammatory markers and outcome in patients with locally advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction. British Journal of Surgery 2017;104:401-7. [DOI: 10.1002/bjs.10425] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
11 Feng L, Gu S, Wang P, Chen H, Chen Z, Meng Z, Liu L. White Blood Cell and Granulocyte Counts Are Independent Predictive Factors for Prognosis of Advanced Pancreatic Caner. Gastroenterol Res Pract 2018;2018:8096234. [PMID: 29853866 DOI: 10.1155/2018/8096234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Choi N, Kim JH, Chie EK, Gim J, Kang HC. A meta-analysis of the impact of neutrophil-to-lymphocyte ratio on treatment outcomes after radiotherapy for solid tumors. Medicine (Baltimore) 2019;98:e15369. [PMID: 31045780 DOI: 10.1097/MD.0000000000015369] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
13 Xu L, Chen J, Guo H, Huang R, Guo L, Yu Y 2nd, Zhai T, Wu F, Chen Z, Li D, Chen C. Distribution of Peripheral Blood Cells in Esophageal Cancer Patients During Concurrent Chemoradiotherapy Predicts Long-Term Locoregional Progression Hazard After Treatment (GASTO1072). Cancer Manag Res 2021;13:4203-15. [PMID: 34079373 DOI: 10.2147/CMAR.S307695] [Reference Citation Analysis]
14 Chan DL, Yao JC, Carnaghi C, Buzzoni R, Herbst F, Ridolfi A, Strosberg J, Kulke MH, Pavel M, Singh S. Markers of Systemic Inflammation in Neuroendocrine Tumors: A Pooled Analysis of the RADIANT-3 and RADIANT-4 Studies. Pancreas 2021;50:130-7. [PMID: 33560090 DOI: 10.1097/MPA.0000000000001745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Khin NS, Tan SH, Wang ML, Siow TR, Lim FL, Wang FQ, Ng MC, Lam JY, Yip C. Chemoradiation-induced changes in systemic inflammatory markers and their prognostic significance in oesophageal squamous cell carcinoma. Br J Radiol 2021;94:20200314. [PMID: 33861156 DOI: 10.1259/bjr.20200314] [Reference Citation Analysis]
16 Karube M, Nakayama H. Proton therapy for patients with esophageal cancer: History, characteristics, clinical outcome and future direction of proton beam therapy. Glob Health Med 2021;3:149-56. [PMID: 34250290 DOI: 10.35772/ghm.2020.01083] [Reference Citation Analysis]
17 Sherry AD, Newman NB, Anderson JL, Osmundson EC. Systemic inflammatory dynamics during chemoradiotherapy predict response, relapse, metastasis, and survival in esophageal carcinoma. J Surg Oncol 2019;121:303-12. [DOI: 10.1002/jso.25793] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Wu CC, Li SH, Lu HI, Lo CM, Wang YM, Chou SY, Chen YH. Inflammation-based prognostic scores predict the prognosis of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a propensity score-matched analysis. PeerJ 2018;6:e5655. [PMID: 30258731 DOI: 10.7717/peerj.5655] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
19 Brkic FF, Kadletz L, Jank B, Cede J, Seemann R, Schneider S, Haymerle G, Parzefall T, Kenner L, Heiduschka G. Pretreatment assessment of hematologic and inflammatory markers in adenoid cystic carcinoma: neutrophil/lymphocyte ratio is associated with multiple recurrences. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2019;127:408-16. [DOI: 10.1016/j.oooo.2018.10.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Nesseler JP, Schaue D, McBride WH, Nickers P. [Inflammatory and immune biomarkers of radiation response]. Cancer Radiother 2018;22:180-92. [PMID: 29650389 DOI: 10.1016/j.canrad.2017.09.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Xu J, Wang Y, Shi J, Liu J, Li Q, Chen L. Combination therapy: A feasibility strategy for CAR-T cell therapy in the treatment of solid tumors. Oncol Lett 2018;16:2063-70. [PMID: 30008901 DOI: 10.3892/ol.2018.8946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
22 Ho YC, Lai YC, Lin HY, Ko MH, Wang SH, Yang SJ, Lin PJ, Chou TW, Hung LC, Huang CC, Chang TH, Lin JB, Lin JC. Low cardiac dose and neutrophil-to-lymphocyte ratio predict overall survival in inoperable esophageal squamous cell cancer patients after chemoradiotherapy. Sci Rep 2021;11:6644. [PMID: 33758232 DOI: 10.1038/s41598-021-86019-2] [Reference Citation Analysis]
23 Pirozzolo G, Gisbertz SS, Castoro C, van Berge Henegouwen MI, Scarpa M. Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis. J Thorac Dis 2019;11:3136-45. [PMID: 31463142 DOI: 10.21037/jtd.2019.07.30] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
24 Gaitanidis A, Patel D, Nilubol N, Tirosh A, Sadowski S, Kebebew E. Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis. Ann Surg Oncol. 2018;25:122-130. [PMID: 29134377 DOI: 10.1245/s10434-017-6241-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
25 Anderson JL, Newman NB, Anderson C, Sherry AD, Yock AD, Osmundson EC. Mean cardiopulmonary dose and vertebral marrow dose differentially predict lineage-specific leukopenia kinetics during radiotherapy for esophageal cancer. Radiother Oncol 2020;152:169-76. [PMID: 32291110 DOI: 10.1016/j.radonc.2019.12.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 van Hootegem SJM, Smithers BM, Gotley DC, Brosda S, Thomson IG, Thomas JM, Gartside M, Barbour AP. Baseline neutrophil-lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy. Dis Esophagus 2020;33:doz082. [PMID: 31676907 DOI: 10.1093/dote/doz082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Turri-zanoni M, Salzano G, Lambertoni A, Giovannardi M, Karligkiotis A, Battaglia P, Castelnuovo P. Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio: Hematologic markers as prognostic factors in sinonasal cancers. Head Neck 2017;39:730-6. [DOI: 10.1002/hed.24681] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
28 Wang C, Zhao K, Hu S, Huang Y, Ma L, Song Y, Li M. A predictive model for treatment response in patients with locally advanced esophageal squamous cell carcinoma after concurrent chemoradiotherapy: based on SUVmean and NLR. BMC Cancer 2020;20:544. [PMID: 32522277 DOI: 10.1186/s12885-020-07040-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Zhang X, Jiang Y, Wang Y, Wang Z, Zhao L, Xue X, Sang S, Zhang L. Prognostic role of neutrophil-lymphocyte ratio in esophageal cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e13585. [PMID: 30544482 DOI: 10.1097/MD.0000000000013585] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
30 Li B, Xiong F, Yi S, Wang S. Prognostic and Clinicopathologic Significance of Neutrophil-to-Lymphocyte Ratio in Esophageal Cancer: An Update Meta-Analysis. Technol Cancer Res Treat 2022;21:15330338211070140. [PMID: 35025614 DOI: 10.1177/15330338211070140] [Reference Citation Analysis]
31 Luo Z, Zhang W, Chen L, Xu N. Prognostic Value of Neutrophil:Lymphocyte and Platelet:Lymphocyte Ratios for 28-Day Mortality of Patients with AECOPD. Int J Gen Med 2021;14:2839-48. [PMID: 34211292 DOI: 10.2147/IJGM.S312045] [Reference Citation Analysis]
32 Hall BM, Geraci TC, Machan JT, Milman S, Adams CA, Cioffi W, Ng T, Monaghan S. Lack of Lymphocyte Recovery After Esophagectomy Predicts Overall and Recurrence-Free Survival. J Surg Res 2020;246:379-83. [PMID: 31676146 DOI: 10.1016/j.jss.2019.09.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Yang X, Huang Y, Feng JF, Liu JS. Prognostic significance of neutrophil-to- lymphocyte ratio in esophageal cancer: a meta-analysis. Onco Targets Ther 2015;8:789-94. [PMID: 25914549 DOI: 10.2147/OTT.S77099] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]